Cargando…

Pitavastatin Exerts Potent Anti-Inflammatory and Immunomodulatory Effects via the Suppression of AP-1 Signal Transduction in Human T Cells

Statins inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase are the standard treatment for hypercholesterolemia in atherosclerotic cardiovascular disease (ASCVD), mediated by inflammatory reactions within vessel walls. Several studies highlighted the pleiotropic effects of statins beyond their lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liv Weichien, Lin, Chin-Sheng, Tsai, Min-Chien, Shih, Shao-Fu, Lim, Zhu Wei, Chen, Sy-Jou, Tsui, Pi-Fen, Ho, Ling-Jun, Lai, Jenn-Haung, Liou, Jun-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678418/ https://www.ncbi.nlm.nih.gov/pubmed/31330988 http://dx.doi.org/10.3390/ijms20143534

Ejemplares similares

Spices and Atherosclerosis
por: Tsui, Pi-Fen, et al.
Publicado: (2018)

Differential effects of triptolide and tetrandrine on activation of COX-2, NF-κB, and AP-1 and virus production in dengue virus-infected human lung cells
por: Liou, Jun-Ting, et al.
Publicado: (2008)

Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
por: Liu, Wei-Ting, et al.
Publicado: (2020)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions
por: Chen, Sy-Jou, et al.
Publicado: (2019)

Chondroprotective Effects and Mechanisms of Dextromethorphan: Repurposing Antitussive Medication for Osteoarthritis Treatment
por: Chen, Liv Weichien, et al.
Publicado: (2018)

Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathways
por: Lai, Jenn-Haung, et al.
Publicado: (2021)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Differential immunomodulatory effects by Tripterygium wilfordii Hook f-derived refined extract PG27 and its purified component PG490 (triptolide) in human peripheral blood T cells: potential therapeutics for arthritis and possible mechanisms explaining in part Chinese herbal theory “Junn-Chenn-Zuou-SS”
por: Ho, Ling-Jun, et al.
Publicado: (2013)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
por: Lai, Jenn-Haung, et al.
Publicado: (2019)

Operation of mitochondrial machinery in viral infection-induced immune responses
por: Lai, Jenn-Haung, et al.
Publicado: (2018)

Arthroprotective Effects of Cf-02 Sharing Structural Similarity with Quercetin
por: Liu, Feng-Cheng, et al.
Publicado: (2018)

Ovotransferrin exerts bidirectional immunomodulatory activities via TLR4‐mediated signal transduction pathways in RAW264.7 cells
por: Ru, Zhiying, et al.
Publicado: (2021)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species
por: Eldesouky, Hassan E., et al.
Publicado: (2020)

Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection
por: Lai, Jenn-Haung, et al.
Publicado: (2017)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Molecular Characteristics and Potent Immunomodulatory Activity of Fasciola hepatica Cystatin
por: Zhang, Kai, et al.
Publicado: (2022)

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
por: Huang, Po-Lin, et al.
Publicado: (2023)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Murine sterile fecal filtrate is a potent pharmacological agent that exerts age-independent immunomodulatory effects in RAW264.7 macrophages
por: Diwan, Bhawna, et al.
Publicado: (2023)

Bacterial flagellin—a potent immunomodulatory agent
por: Hajam, Irshad A, et al.
Publicado: (2017)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
por: Huang, Po-Lin, et al.
Publicado: (2023)

Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein
por: He, Runtao, et al.
Publicado: (2003)

A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes
por: Lee, Chia-Chung, et al.
Publicado: (2016)

Sialic-Acid-Related Enzymes of B Cells and Monocytes as Novel Markers to Discriminate Improvement Categories and to Fulfill Two Remission Definitions in Rheumatoid Arthritis
por: Liou, Lieh-Bang, et al.
Publicado: (2023)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Chest pain as a possible side effect of pitavastatin (Livalo)
por: AlZahrani, Nada R., et al.
Publicado: (2019)

Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
por: Makuc, Damjan, et al.
Publicado: (2013)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a
por: Lee, Naeun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_il3kpt3tnlloi7ka6emf07ud0m